Literature DB >> 2144027

Clinical and pathological effects of the dermonecrotic toxin of Bordetella bronchiseptica and Pasteurella multocida in specific-pathogen-free piglets.

B Eliás1, G Boros, M Albert, S Tuboly, P Gergely, L Papp, I Barna Vetró, P Rafai, E Molnár.   

Abstract

The role of dermonecrotic toxin (DNT) of Bordetella bronchiseptica and Pasteurella multocida, purified by repeated chromatography in Sephacryl S-200 gel, in the pathogenesis of atrophic rhinitis (AR) of swine was studied bacteriologically, clinically and pathologically. Two-week-old specific pathogen-free (SPF) piglets were parenterally treated with 30 micrograms of DNT 3 times at 2-day interval and 7-week-old piglets were treated with 15 micrograms of DNT twice a week for 5 weeks. In 2- to 3-week-old piglets, both B. bronchiseptica DNT and P. multocida DNT produced nasal turbinate lesions with similar severity, characterized by damage of the cilia, epithelial metaplasia, intensive proliferation of osteoblasts, regressive changes, and diffuse osteocytic osteolysis. In 7- to 12-week-old piglets, treatment with B. bronchiseptica DNT failed to produce progressive changes in the nasal turbinates. Histopathological examination revealed osteogenic processes and osteoid synthesis besides the proliferation of osteoblasts and mild osteocytic osteolysis. Moreover, severe gross pathological lesions developed in the stomach, liver, kidneys, and lymphoid organs. The piglets' appetite and body weight gain gradually decreased during the DNT treatment and in the last week when the toxic signs appeared. Treatment of 7- to 12-week-old piglets with P. multocida DNT resulted in progressive AR. Histopathologically, diffuse osteocytic osteolysis was observed in the nasal turbinates. Neither clinical signs nor pathological lesions of the visceral organs developed in these piglets. The authors emphasize that the DNT of B. bronchiseptica basically differs from that of P. multocida in biological properties, though there are certain similarities between the DNTs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144027     DOI: 10.1292/jvms1939.52.677

Source DB:  PubMed          Journal:  Nihon Juigaku Zasshi        ISSN: 0021-5295


  5 in total

1.  Association of Pasteurella multocida toxin with vimentin.

Authors:  Hiroaki Shime; Takahiro Ohnishi; Kaori Nagao; Kiyomasa Oka; Toshifumi Takao; Yasuhiko Horiguchi
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Crystallization and preliminary crystallographic studies of the Pasteurella multocida toxin catalytic domain.

Authors:  Masayuki Miyazawa; Kengo Kitadokoro; Shigeki Kamitani; Hiroaki Shime; Yasuhiko Horiguchi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-18

Review 3.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

4.  Stimulation of DNA synthesis in osteoblast-like MC3T3-E1 cells by Bordetella bronchiseptica dermonecrotic toxin.

Authors:  Y Horiguchi; N Sugimoto; M Matsuda
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  Purified Pasteurella multocida protein toxin reduces acid phosphatase-positive osteoclasts in the ventral nasal concha of gnotobiotic pigs.

Authors:  M R Ackermann; D A Adams; L L Gerken; M J Beckman; R B Rimler
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.